Zoetis Balance Sheet Health
Financial Health criteria checks 4/6
Zoetis has a total shareholder equity of $4.7B and total debt of $6.6B, which brings its debt-to-equity ratio to 141.9%. Its total assets and total liabilities are $14.1B and $9.4B respectively. Zoetis's EBIT is $3.4B making its interest coverage ratio 27.7. It has cash and short-term investments of $1.7B.
Key information
141.91%
Debt to equity ratio
US$6.61b
Debt
| Interest coverage ratio | 27.7x |
| Cash | US$1.74b |
| Equity | US$4.66b |
| Total liabilities | US$9.44b |
| Total assets | US$14.10b |
Recent financial health updates
Is Zoetis (NYSE:ZTS) Using Too Much Debt?
Jan 31
Zoetis (NYSE:ZTS) Has A Pretty Healthy Balance Sheet
Oct 26Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?
Jul 16Recent updates
Zoetis Inc.'s (NYSE:ZTS) Intrinsic Value Is Potentially 41% Above Its Share Price
Apr 30Zoetis Inc. (NYSE:ZTS) Investors Are Less Pessimistic Than Expected
Apr 02Zoetis: Lots Of Growth Opportunities For This High-Quality Compounder
Mar 25Zoetis: Focusing On The High Margin Segments
Mar 13Zoetis Inc. (NYSE:ZTS) Yearly Results: Here's What Analysts Are Forecasting For This Year
Feb 15Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity
Feb 13Is Zoetis (NYSE:ZTS) Using Too Much Debt?
Jan 31Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 33%?
Jan 10The Wall Street Journal Vs. Zoetis
Dec 26Zoetis: Are Competition And Price Increases A Cause For Concern?
Dec 06Zoetis: Healing Paws, Growing Profits
Nov 29Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy
Nov 18Zoetis (NYSE:ZTS) Has A Pretty Healthy Balance Sheet
Oct 26Zoetis: A Solid Choice For The Young Dividend Growth Investor
Oct 09Do Zoetis' (NYSE:ZTS) Earnings Warrant Your Attention?
Oct 08Zoetis: Investing In Pet Health And Portfolio Wealth
Sep 26Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 23%?
Sep 20There's Reason For Concern Over Zoetis Inc.'s (NYSE:ZTS) Price
Aug 30Zoetis: Librela Sales Should Peak 200-300% Above Management's $1B Target
Aug 13Zoetis Q2 Earnings: Harvesting From DTC (Rating Upgrade)
Aug 07Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?
Jul 16Zoetis: A High-Quality Business And Fast Dividend Growth At A Reasonable Price
Jul 03Zoetis: Don't Fret Excessively Over The Animal Healthcare Leader
Jun 11A Look At The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)
Jun 10Zoetis (NYSE:ZTS) Ticks All The Boxes When It Comes To Earnings Growth
May 23Zoetis: Why The Focus On Companion Animal Segment Will Pay Off
May 22Zoetis: Long-Term Buy Despite Safety Concerns
May 03Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment
Apr 15Zoetis: My Favorite Healthcare Stock Right Now
Mar 21Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness
Feb 27Animal Kingdom's Ally: Zoetis And Its Path To 10%+ Returns
Jan 10Zoetis: High-Quality Compounder With A Reasonable Price After Earnings
Nov 09Zoetis: Significant CapEx Investments For Long-Term Growth, But A Hold Now
Oct 26Zoetis Is An Impressive Healthcare Compounder
Sep 26Financial Position Analysis
Short Term Liabilities: ZTS's short term assets ($5.9B) exceed its short term liabilities ($3.4B).
Long Term Liabilities: ZTS's short term assets ($5.9B) do not cover its long term liabilities ($6.1B).
Debt to Equity History and Analysis
Debt Level: ZTS's net debt to equity ratio (104.5%) is considered high.
Reducing Debt: ZTS's debt to equity ratio has reduced from 236% to 141.9% over the past 5 years.
Debt Coverage: ZTS's debt is well covered by operating cash flow (44.6%).
Interest Coverage: ZTS's interest payments on its debt are well covered by EBIT (27.7x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/19 16:21 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Zoetis Inc. is covered by 42 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Ishan Majumdar | Baptista Research |
| Douglas Tsao | Barclays |